Pascal Soriot
Pharma

AZ sets sights on 25+ blockbusters by 2030

Analysts are heavily focused on AZ’s clinical programs, wondering whether it can repeat the level of phase 3 successes it enjoyed last year.
Angus Liu Feb 10, 2026 11:20am
Open door symbolizing exit

Beleaguered CSL announces surprise CEO retirement

Feb 10, 2026 10:45am
Community oncologys growing role in the future of cancer care

Community oncology’s growing role in the future of cancer care

Feb 9, 2026 8:00am
Narasimhan

Novartis CEO pay soars 30% to $32M in 2025

Feb 9, 2026 3:54pm
heart stop delay heart stop stoplight red light

NIH stops Xarelto arm of stroke trial due to safety, efficacy

Feb 10, 2026 4:04pm
Jakafi

Incyte reports Opzelura sales up 33% in 2025, plots '26 growth

Feb 10, 2026 11:48am
More News

FDA untitled letters target drug ads from Novo, argenx, Sobi

Feb 10, 2026 11:42am

Moderna forms long-term mRNA vaccine supply pact with Mexico

Feb 10, 2026 11:36am

Novo's Wegovy spot tops pharma Super Bowl engagement rankings

Feb 9, 2026 5:00pm
Fierce Biotech

BMS and Evinova pen global development partnership

Feb 9, 2026 2:33pm